Loading...
Loading...
Among the 2 tracked institutional investors we monitor, AEON (AEON BIOPHARMA INC) is held with a combined value of $112.40K across 103,167 shares. The largest holder is VANGUARD GROUP INC with a position worth $110.37K. 1 fund increased its holdings.
Total Institutional Value
$112.40K
Total Shares Held
103,167
Institutional Holders
2
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $110.37K | 0.00% | +1.8% |
| 2 | BlackRock, Inc. | $2.04K | 0.00% | - |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of AEON with a position worth $110.37K, representing 0.00% of their portfolio. In total, 2 institutional investors hold AEON with a combined value of $112.40K.
Institutional investors hold $112.40K worth of AEON stock across 2 positions. The largest institutional holder is VANGUARD GROUP INC with $110.37K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For AEON, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their AEON positions.
| 2026-07-21 |
SEC Schedule 13D (activist) and 13G (passive) filings for AEON. Filed when an investor acquires 5%+ ownership.
Last Close
$0.19
2026-08-21
YTD
-82.7%
0% of 52-week range